Why JBSS32 Plunged: Inside JBS's Third-Quarter Profit Drop

JBSS32 shares are falling because, according to the earnings report released by JBS, third-quarter 2026 net income shrank from $581 million to $164 million year-over-year—a 71.7% drop. The figure came in below market expectations: operational cash generation, or adjusted EBITDA, totaled $1.18 billion, compared with the $1.32 billion projected by analysts surveyed by LSEG. When results disappoint the consensus, the reaction is typically selling pressure—and that is what happened to the stock.

Why Are JBSS32 Shares Falling?

Because the third quarter was weak and fell short of expectations. JBS delivered lower profit, thinner margins, and, for the first time in several quarters, burned cash. The stock's pullback—from around R$ 72 down to the R$ 65 range the day after the earnings release—reflects the market repricing the company in the face of a more difficult-than-expected result.

It is worth separating fact from interpretation. The facts are in the financial statements: earnings per share declined from $0.52 to $0.15 over the year. In reais, the company reported R$ 702 million, nearly 80% below the R$ 3.51 billion from a year earlier, with a net margin of just 0.74% on revenue. The market's interpretation is that the worst of the cycle has not yet passed.

What Actually Weighed on the Results

Revenue remained virtually unchanged: JBS posted $22.7 billion in revenue for the quarter, up 0.6% over the same period last year. In other words, the company sold essentially the same amount of meat—the problem lay in margins, not volume. Adjusted operational income dropped by more than half, to $597 million, and the cash generation margin shrank by nearly three percentage points. The difference between what comes in from sales and what remains after costs explains the disappointment.

This margin compression stems from three drivers, all cited by the company. The first is North American cattle costs: the U.S. cattle cycle is at its lowest livestock supply point, and lower animal imports from Mexico drove up raw material costs for U.S. plants. The second is an oversupply of pork globally, which squeezed the pork division's margin to just 2%. The third comes from Brazil, where the beef export quota to China ran out earlier than expected—the same type of trade squeeze we previously observed when China applied extra tariffs and exhausted the sector's beef quota.

There is a fourth, less obvious factor: the $167 million negative cash flow came not only from lower cash generation, but also from a deliberate inventory-building choice. JBS built up inventories of grain and Seara poultry for shipment to Europe, alongside beef inventories to take advantage of Chinese quotas in the fourth quarter. Working capital consumed today can translate into revenue tomorrow, but that will only be confirmed in the next earnings report.

Not Everything Was Bad: A Mixed Performance

Strong and struggling businesses coexist within the same quarter, and this combination helps clarify where the company may be heading.

CEO Wesley Batista Filho called 2026 "the most difficult year" for the North American beef operation, according to the earnings release. He said he expects 2027 to be "substantially better" as Mexican cattle imports normalize around 1 million head per year. The promise makes sense given the history of the U.S. cattle cycle—but it is a promise, not a figure already reflected on the balance sheet. This bet on a recovery was already in the air when a BofA report pointed to a global rise in cattle prices and JBSS32 surged in October; now the market is demanding delivery.

The Flora Acquisition and a Point Worth Watching

Alongside the earnings, JBS announced the acquisition of 100% of Flora—the hygiene and beauty brand owned by the J&F group itself—for an enterprise value of R$ 2.97 billion ($542 million). The financial structure was designed to avoid draining cash: $367 million will be paid using treasury shares, and JBS will assume $175 million in Flora debt. The company states that the transaction will not increase net leverage, and closing is expected in December. We detailed the terms in our article covering the Flora acquisition and the use of treasury shares.

What This Means for Current and Prospective Shareholders

JBS's leverage rose from 2.39 to 3.54 times EBITDA over the year. With net debt of $19.3 billion and available liquidity of $8.2 billion, the company is not facing immediate financial risk—but for a meatpacker in a downturn cycle, rising leverage is the metric the market monitors closely. For the first nine months of 2026 combined, net income reached $283 million, down 82% from $1.61 billion in the same period last year.

Analyst sentiment remains divided. Genial maintained its buy rating but cut its price target to $15.50 per share (equivalent to about R$ 85 per BDR), down from $17.50 previously. Morgan Stanley characterized the quarter as more difficult than expected. It makes sense to view the results within sector context: meatpackers do not operate in a vacuum, and labor cost pressures also factor into the equation—as we analyzed when discussing the impact of ending the 6-day workweek on listed meatpackers.